WALTHAM, Mass.--(BUSINESS WIRE)--Regulatory News: OXiGENE, Inc. (NASDAQ: OXGN) (XSSE: OXGN), a clinical-stage, biopharmaceutical company developing novel therapeutics to treat cancer and eye diseases, announced today that OXiGENE President and CEO, Dr. Richard Chin, will present at the BIO Investor Forum at the Palace Hotel in San Francisco on Thursday, October 11, at 10:00 a.m. PDT / 1:00 p.m. EDT.
